Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2005

01-10-2005 | Case Report

West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis

Authors: John A. Batsis, Michael P. Phy

Published in: Clinical Rheumatology | Issue 5/2005

Login to get access

Abstract

The clinical presentation of West Nile virus (WNV) can be severe in immunosuppressed patients. A 65-year-old with steroid-dependent rheumatoid arthritis on infliximab and methotrexate presented with meningitis and profound muscular weakness. Serum WNV IgM and IgG antibody were positive. WNV should be included in the differential diagnosis of neurological symptoms in peak months.
Literature
1.
Outbreak of West Nile-like viral encephalitis—New York, 1999. MMWR Morb Mortal Wkly Rep 1999;48:845–849
2.
Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion—Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:879
3.
Giladi M, Metzkor-Cotter E, Martin DA et al (2001) West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 7:659–661
4.
5.
6.
Nash D, Mostashari F, Fine A et al (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344:1807–1814
7.
Diamond MS, Shrestha B, Marri A, Mahan D, Engle M (2003) B cells and antibody play critical roles in the immediate defence of disseminated infection by West Nile encephalitis virus. J Virol 77:2578–2586
8.
Petersen LR, Marfin AA (2002) West Nile virus: a primer for the clinician. Ann Intern Med 137:173–179
9.
Feinstein S, Akov Y, Lachmi B-E, Lehrer S, Rannon L, Katz D (1985) Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA). J Med Virol 17:63–72
10.
Kolb AF, Pewe L, Webster J, Perlman S, Whitelaw CB, Siddell SG (2001) Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis. J Virol 75:2803–2809
Metadata
Title
West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis
Authors
John A. Batsis
Michael P. Phy
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1085-x

Other articles of this Issue 5/2005

Clinical Rheumatology 5/2005 Go to the issue

Original Article

Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis

Case Report

Massive Gorham-Stout syndrome of the pelvis

Original Article

Vasculitic complications of interferon-α treatment for chronic hepatitis C virus infection: case report and review of the literature

Case Report

Idiopathic portal hypertension associated with systemic sclerosis and Sjögren’s syndrome

Case Report

Osteogenesis imperfecta: a case with hand deformities

Original Article

Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits